Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH, Wang Y, Yang JY, Li J, Feng MX, Wang YH, Yang XM, He P, Tian GA, Zhang XX, Li Q, Cao XY, Huo YM, Yang MW, Fu XL, Li J, Liu DJ, Dai M, Wen SY, Gu JR, Hong J, Hua R, Zhang ZG, Sun YW.
Jiang SH, et al.
Oncotarget. 2016 Jan 26;7(4):4226-40. doi: 10.18632/oncotarget.6772.
Oncotarget. 2016.
PMID: 26735172
Free PMC article.